Review



af2126  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    R&D Systems af2126
    Af2126, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/af2126/product/R&D Systems
    Average 92 stars, based on 8 article reviews
    af2126 - by Bioz Stars, 2026-03
    92/100 stars

    Images



    Similar Products

    92
    R&D Systems af2126
    Af2126, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/af2126/product/R&D Systems
    Average 92 stars, based on 1 article reviews
    af2126 - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    92
    R&D Systems lyve1
    Lyve1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lyve1/product/R&D Systems
    Average 92 stars, based on 1 article reviews
    lyve1 - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    94
    R&D Systems chl 1
    Chl 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chl 1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    chl 1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    R&D Systems human chl1
    ( A ) Relative mRNA expression levels of pan <t>CHL1,</t> and isoforms 1 and 2 in primary GIST, ( B ) Western blot analyses of CHL1 protein expression in primary tumors and metastases.
    Human Chl1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human chl1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    human chl1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    R&D Systems chl1
    Expression of <t>CHL1</t> and NrCAM in pediatric neuroblastoma. Representative examples of CHL1 positive (A) and CHL-1 negative (B) (magnification x100) as well as NrCAM positive (C) and NrCAM negative (D) immunostaining (magnification x200).
    Chl1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chl1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    chl1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    R&D Systems chl1 primary antibody
    Expression of <t>CHL1</t> and NrCAM in pediatric neuroblastoma. Representative examples of CHL1 positive (A) and CHL-1 negative (B) (magnification x100) as well as NrCAM positive (C) and NrCAM negative (D) immunostaining (magnification x200).
    Chl1 Primary Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chl1 primary antibody/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    chl1 primary antibody - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Relative mRNA expression levels of pan CHL1, and isoforms 1 and 2 in primary GIST, ( B ) Western blot analyses of CHL1 protein expression in primary tumors and metastases.

    Journal: Oncotarget

    Article Title: Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power

    doi: 10.18632/oncotarget.27525

    Figure Lengend Snippet: ( A ) Relative mRNA expression levels of pan CHL1, and isoforms 1 and 2 in primary GIST, ( B ) Western blot analyses of CHL1 protein expression in primary tumors and metastases.

    Article Snippet: A polyclonal antibody raised against the extracellular domain of human CHL1 (CHL1/L1CAM-2 (AF2126; R&D Systems, USA) was used.

    Techniques: Expressing, Western Blot

    ( A ) Recurrence free survival for local CHL1 expression, ( B ) Overall survival for local CHL1 expression, ( C ) Recurrence free survival for serum CHL1 levels with cut-off values at 11.0 ng/ml, ( D ) Overall survival for serum CHL1 levels with cut-off values at 11.0 ng/ml, ( E ) Recurrence free survival for serum CHL1 levels with cut-off values at 14.5 ng/ml, ( F ) Overall survival for serum CHL1 levels with cut-off values at 14.5 ng/ml.

    Journal: Oncotarget

    Article Title: Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power

    doi: 10.18632/oncotarget.27525

    Figure Lengend Snippet: ( A ) Recurrence free survival for local CHL1 expression, ( B ) Overall survival for local CHL1 expression, ( C ) Recurrence free survival for serum CHL1 levels with cut-off values at 11.0 ng/ml, ( D ) Overall survival for serum CHL1 levels with cut-off values at 11.0 ng/ml, ( E ) Recurrence free survival for serum CHL1 levels with cut-off values at 14.5 ng/ml, ( F ) Overall survival for serum CHL1 levels with cut-off values at 14.5 ng/ml.

    Article Snippet: A polyclonal antibody raised against the extracellular domain of human CHL1 (CHL1/L1CAM-2 (AF2126; R&D Systems, USA) was used.

    Techniques: Expressing

    Association of clinicopathological characteristics of GIST patients with local  CHL1  expression and serum  CHL1  levels (cut-off 11.0 ng/ml)

    Journal: Oncotarget

    Article Title: Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power

    doi: 10.18632/oncotarget.27525

    Figure Lengend Snippet: Association of clinicopathological characteristics of GIST patients with local CHL1 expression and serum CHL1 levels (cut-off 11.0 ng/ml)

    Article Snippet: A polyclonal antibody raised against the extracellular domain of human CHL1 (CHL1/L1CAM-2 (AF2126; R&D Systems, USA) was used.

    Techniques: Expressing

    Serum CHL1 levels in GIST ( A ) Serum CHL1 levels of patients with GIST and healthy controls. ( B ) Receiver operating characteristic (ROC) curves of serum CHL1 levels for detecting GIST.

    Journal: Oncotarget

    Article Title: Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power

    doi: 10.18632/oncotarget.27525

    Figure Lengend Snippet: Serum CHL1 levels in GIST ( A ) Serum CHL1 levels of patients with GIST and healthy controls. ( B ) Receiver operating characteristic (ROC) curves of serum CHL1 levels for detecting GIST.

    Article Snippet: A polyclonal antibody raised against the extracellular domain of human CHL1 (CHL1/L1CAM-2 (AF2126; R&D Systems, USA) was used.

    Techniques:

    Prognostic value of serum  CHL1  levels for recurrence free survival

    Journal: Oncotarget

    Article Title: Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power

    doi: 10.18632/oncotarget.27525

    Figure Lengend Snippet: Prognostic value of serum CHL1 levels for recurrence free survival

    Article Snippet: A polyclonal antibody raised against the extracellular domain of human CHL1 (CHL1/L1CAM-2 (AF2126; R&D Systems, USA) was used.

    Techniques:

    Expression of CHL1 and NrCAM in pediatric neuroblastoma. Representative examples of CHL1 positive (A) and CHL-1 negative (B) (magnification x100) as well as NrCAM positive (C) and NrCAM negative (D) immunostaining (magnification x200).

    Journal: Open Medicine

    Article Title: CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma

    doi: 10.1515/med-2019-0109

    Figure Lengend Snippet: Expression of CHL1 and NrCAM in pediatric neuroblastoma. Representative examples of CHL1 positive (A) and CHL-1 negative (B) (magnification x100) as well as NrCAM positive (C) and NrCAM negative (D) immunostaining (magnification x200).

    Article Snippet: Afterwards, the primary antibody either specific for CHL1 (goat, polyclonal antibody: AF2126, R&D Systems, MN, USA) or NrCAM (goat anti-human NrCAM antibody: AF2034, R&D Systems, MN, USA,) was applied at 37°C and pH 9.1 for 60 minutes.

    Techniques: Expressing, Immunostaining

    Kaplan-Meier survival curves for overall and event-free survival. No association was found for CHL1-expression (A/B). Survival rates were better by trend in children with NrCAM positive tumors (C/D) but without statistical significance (p=0.07 and p=0.06).

    Journal: Open Medicine

    Article Title: CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma

    doi: 10.1515/med-2019-0109

    Figure Lengend Snippet: Kaplan-Meier survival curves for overall and event-free survival. No association was found for CHL1-expression (A/B). Survival rates were better by trend in children with NrCAM positive tumors (C/D) but without statistical significance (p=0.07 and p=0.06).

    Article Snippet: Afterwards, the primary antibody either specific for CHL1 (goat, polyclonal antibody: AF2126, R&D Systems, MN, USA) or NrCAM (goat anti-human NrCAM antibody: AF2034, R&D Systems, MN, USA,) was applied at 37°C and pH 9.1 for 60 minutes.

    Techniques: Expressing

     CHL1  expression as well as clinical, pathologic and molecular characteristics of the analysed neuroblastoma tissue samples. Statistical analyses by using cross-tables, two-sided Fisher´s and Chi-squared test.

    Journal: Open Medicine

    Article Title: CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma

    doi: 10.1515/med-2019-0109

    Figure Lengend Snippet: CHL1 expression as well as clinical, pathologic and molecular characteristics of the analysed neuroblastoma tissue samples. Statistical analyses by using cross-tables, two-sided Fisher´s and Chi-squared test.

    Article Snippet: Afterwards, the primary antibody either specific for CHL1 (goat, polyclonal antibody: AF2126, R&D Systems, MN, USA) or NrCAM (goat anti-human NrCAM antibody: AF2034, R&D Systems, MN, USA,) was applied at 37°C and pH 9.1 for 60 minutes.

    Techniques: Expressing, Amplification